0.5796

2.66% 0.015

Neuroone Medical Technologies Corp (NMTC)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$0.5646

Aprire:

$0.5775

Volume 24 ore:

476.66K

Relative Volume:

1.77

Capitalizzazione di mercato:

$26.17M

Reddito:

$2.82M

Utile/perdita netta:

$-13.47M

Rapporto P/E:

-0.8524

EPS:

-0.68

Flusso di cassa netto:

$-13.61M

1 W Prestazione:

+34.73%

1M Prestazione:

-46.33%

6M Prestazione:

-37.68%

1 anno Prestazione:

-50.40%

Intervallo 1D:

$0.57

$0.61

Intervallo di 1 settimana:

$0.4429

$0.61

Portata 52W:

$0.3954

$1.39

Neuroone Medical Technologies Corp Stock (NMTC) Company Profile

Nome

Neuroone Medical Technologies Corp

Settore

Healthcare (1151)

Industria

Medical Devices (153)

Telefono

(952) 426-1383

Indirizzo

7599 ANAGRAM DR, EDEN PRAIRIE

Dipendente

Cinguettio

Prossima data di guadagno

2024-08-14

Ultimi documenti SEC

NMTC's Discussions on Twitter

Confronta NMTC con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
NMTC	0.99	0	0	0	0	0.00
MOBBW Mobilicom Limited Warrants	0.2623	398.00M	0	0	0	0.00
GOODO Gladstone Commercial Corporation	20.21	372.90M	0	0	0	0.00
PSNYW Polestar Automotive Holding Uk	0.1717	347.36M	2.07B	-1.42B	-1.37B	-0.6765
JUNE Dhandho Junoon Etf	11.11	204.17M	0	0	0	0.00
SHMD Schmid Group N V	2.91	131.34M	0	0	0	0.00

Neuroone Medical Technologies Corp Stock (NMTC) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2022-03-29	Downgrade	Craig Hallum	Buy → Hold

Neuroone Medical Technologies Corp Borsa (NMTC) Ultime notizie

Apr 16, 2025

NeuroOne Medical (NMTC) Expands Partnership with Zimmer Biomet and Secures Funding | NMTC Stock News - GuruFocus

Apr 16, 2025

Neuroone Medical Technologies Corp -Company Now Fully Funded Through At Least Fiscal 2026 - marketscreener.com

Apr 16, 2025

NeuroOne secures funding through fiscal 2026, unaffected by tariffs - Investing.com

Apr 16, 2025

NeuroOne Secures $11.3M in Fresh Capital, Forecasts Triple-Digit Growth - Stock Titan

Apr 16, 2025

Apr 15, 2025

NeuroOne Medical (NMTC) Gains Attention with Successful Pediatri - GuruFocus

Apr 15, 2025

Apr 14, 2025

Breakthrough: Teen Goes from 10 Seizures Per Night to Zero with New Brain Treatment - Stock Titan

Apr 14, 2025

Apr 10, 2025

Ronald McClurg Spends US$100k On NeuroOne Medical Technologies Stock - Yahoo

Apr 10, 2025

Apr 07, 2025

NeuroOne Medical Technologies CEO buys $50,000 in common stock - Investing.com Australia

Apr 07, 2025

NeuroOne Medical Technologies CEO buys $50,000 in common stock By Investing.com - Investing.com South Africa

Apr 07, 2025

NeuroOne Medical’s CFO Ronald McClurg buys $100,000 in stock By Investing.com - Investing.com South Africa

Apr 07, 2025

NeuroOne Announces Proposed Public Offering Of Common Stock To Raise Capital For Growth - Nasdaq

Apr 04, 2025

Neuroone stock hits 52-week low at $0.48 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025

Neuroone stock hits 52-week low at $0.48 amid market challenges - Investing.com

Apr 04, 2025

NeuroOne (NMTC) Announces $8 Million Public Offering - GuruFocus

Apr 04, 2025

Dow Tumbles 1,100 Points; US Economy Adds 228,000 Jobs In March - Benzinga

Apr 04, 2025

NeuroOne Medical Technologies prices $8 million public offering of common stock - MSN

Apr 04, 2025

NeuroOne sets price for 16 million share offering - Investing.com

Apr 04, 2025

NeuroOne Raises $8M: Inside the Major Public Offering That's Catching Investor Attention - Stock Titan

Apr 04, 2025

Guess, Simulations Plus And 3 Stocks To Watch Heading Into Friday - Benzinga

Apr 04, 2025

Apr 03, 2025

NeuroOne announces public offering of common stock - Investing.com

Apr 03, 2025

NeuroOne Medical Announces Strategic Stock Offering with Ladenburg Thalmann - Stock Titan

Apr 03, 2025

Apr 02, 2025

Fostering clinician-led biotech innovation - Medical Economics

Apr 02, 2025

Mar 18, 2025

Game-Changing Epilepsy Innovation: NeuroOne's FDA-Cleared Device Transforms Brain Treatment - StockTitan

Mar 18, 2025

NeuroOne CEO Joins Today's Marketplace To Discuss The Latest Treatments for Epilepsy - Quantisnow

Mar 18, 2025

Breakthrough: First-Ever FDA-Cleared Device Transforms Epilepsy Treatment for 50M Patients - StockTitan

Mar 18, 2025

Mar 14, 2025

Tariffs and medical devices: What has the industry response been? - Medical Economics

Mar 14, 2025

Mar 11, 2025

NeuroOne Targets May 2025 FDA Submission For OneRF Trigeminal Nerve Ablation System - Nasdaq

Mar 11, 2025

NeuroOne accelerates FDA submission timeline for nerve ablation tech - Mass Device

Mar 11, 2025

NeuroOne speeds up FDA submission for nerve ablation system - Investing.com

Mar 11, 2025

NeuroOne Speeds Up FDA Timeline: Revolutionary Facial Pain Treatment Could Hit Market Earlier Than Expected - StockTitan

Mar 11, 2025

Mar 05, 2025

NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference - Barchart

Mar 05, 2025

Can NeuroOne's Upcoming Investor Presentation Signal New Growth in Neurological Tech? - StockTitan

Mar 05, 2025

Feb 17, 2025

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q1 2025 Earnings Call Transcript - MSN

Feb 17, 2025

Feb 14, 2025

Earnings call transcript: NeuroOne Medical sees Q1 2025 revenue surge - MSN

Feb 14, 2025

Feb 13, 2025